We are live on
!
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
+8.61%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$1.64B
AUM Growth
+$187M
(+13%)
Cap. Flow
+$71.3M
Cap. Flow
% of AUM
4.35%
Top 10 Holdings %
Top 10 Hldgs %
34.16%
Holding
1,186
New
96
Increased
395
Reduced
336
Closed
133
Avg Time Held
3.1
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$50.4M |
| 2 |
State Street SPDR Portfolio Emerging Markets ETF
SPEM
|
+$30.6M |
| 3 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$21M |
| 4 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$20.1M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$11.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-10 Year TIPS ETF
TIPX
|
+$52.5M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$21M |
| 3 |
State Street Blackstone Senior Loan ETF
SRLN
|
+$10.9M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$10.7M |
| 5 |
iShares MSCI EAFE Small-Cap ETF
SCZ
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.61% |
| 2 | Technology | 6.07% |
| 3 | Healthcare | 4.8% |
| 4 | Financials | 4.31% |
| 5 | Energy | 3.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Goldman Sachs
GS
$257B
| $10.5M | 0.64% |
30,690
+704
| +2% | +$245K |
2013 Q2
38 quarters
|
|
27
Vanguard High Dividend Yield ETF
VYM
$81.6B
| $10.5M | 0.64% |
97,278
-21,454
| -18% | -$2.28M |
2013 Q2
38 quarters
|
|
28
RTX Corp
RTX
$261B
| $10.5M | 0.64% |
103,990
+1,653
| +2% | +$155K |
2013 Q2
38 quarters
|
|
29
Procter & Gamble
PG
$370B
| $10.3M | 0.63% |
67,913
+2,452
| +4% | +$344K |
2013 Q2
38 quarters
|
|
30
iShares S&P 500 Growth ETF
IVW
$76.7B
| $9.57M | 0.58% |
163,554
+19,752
| +14% | +$1.19M |
2013 Q2
38 quarters
|
|
31
Elevance Health
ELV
$92.9B
| $9.38M | 0.57% |
18,286
+84
| +0.5% | +$42.6K |
2017 Q2
22 quarters
|
|
32
iShares US Medical Devices ETF
IHI
$3.73B
| $8.66M | 0.53% |
164,690
+2,656
| +2% | +$135K |
2021 Q1
7 quarters
|
|
33
JPMorgan Core Plus Bond ETF
JCPB
$15.8B
| $8.51M | 0.52% |
185,306
+178,803
| +2,750% | +$8.21M |
2020 Q1
11 quarters
|
|
34
JPMorgan Equity Premium Income ETF
JEPI
$45.8B
| $8.41M | 0.51% |
154,359
+34,726
| +29% | +$1.89M |
2021 Q1
7 quarters
|
|
35
D.R. Horton
DHI
$39B
| $8.36M | 0.51% |
93,746
+1,496
| +2% | +$120K |
2017 Q1
23 quarters
|
|
36
Broadcom
AVGO
$1.57T
| $8.34M | 0.51% |
149,170
+3,400
| +2% | +$170K |
2014 Q4
32 quarters
|
|
37
Motorola Solutions
MSI
$76.6B
| $8.1M | 0.49% |
31,441
-366
| -1% | -$91.5K |
2019 Q4
12 quarters
|
|
38
Air Products & Chemicals
APD
$66.7B
| $8.08M | 0.49% |
26,205
+559
| +2% | +$158K |
2017 Q2
22 quarters
|
|
39
Visa
V
$756B
| $7.95M | 0.49% |
38,265
+998
| +3% | +$201K |
2013 Q2
38 quarters
|
|
40
Morgan Stanley
MS
$284B
| $7.72M | 0.47% |
90,838
+1,338
| +1% | +$114K |
2017 Q3
21 quarters
|
|
41
Bunge Global
BG
$20.4B
| $7.54M | 0.46% |
+75,525
| New | +$7.25M |
2022 Q4
0 quarters
|
|
42
Merck
MRK
$360B
| $7.48M | 0.46% |
67,446
+323
| +0.5% | +$33K |
2013 Q2
38 quarters
|
|
43
Schwab US Dividend Equity ETF
SCHD
$115B
| $7.47M | 0.46% |
296,622
+5,643
| +2% | +$139K |
2019 Q1
15 quarters
|
|
44
WisdomTree Emerging Markets High Dividend Fund
DEM
$4.11B
| $7.4M | 0.45% |
207,590
-1,852
| -0.9% | -$64.2K |
2022 Q1
3 quarters
|
|
45
Vanguard Dividend Appreciation ETF
VIG
$113B
| $7.4M | 0.45% |
48,722
-673
| -1% | -$100K |
2016 Q3
25 quarters
|
|
46
Chevron
CVX
$441B
| $7.25M | 0.44% |
40,407
-505
| -1% | -$88.1K |
2013 Q2
38 quarters
|
|
47
EOG Resources
EOG
$82.9B
| $7.1M | 0.43% |
54,854
+53,474
| +3,875% | +$7.11M |
2021 Q1
7 quarters
|
|
48
Becton Dickinson
BDX
$52.2B
| $6.96M | 0.42% |
27,367
+1,275
| +5% | +$301K |
2017 Q2
22 quarters
|
|
49
VanEck Short High Yield Muni ETF
SHYD
$486M
| $6.96M | 0.42% |
312,507
+11,778
| +4% | +$259K |
2022 Q2
2 quarters
|
|
50
Abbott
ABT
$181B
| $6.86M | 0.42% |
62,466
+2,255
| +4% | +$233K |
2017 Q2
22 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q4 2022 Portfolio in Review
As of Q4 2022, Capital Analysts LLC held 1,186 positions worth $1.64B, up 13% from $1.45B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Capital Analysts LLC deployed $71.3M of net new capital in Q4 2022, opening 96 new positions and adding to 395 existing holdings. Its largest new stake was Bunge Global: 75,525 shares worth $7.54M.
By sector, the portfolio is most concentrated in Miscellaneous at 70% of assets, down from 70% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR Bloomberg 1-10 Year TIPS ETF, an estimated $52.5M trimmed.
- Capital Analysts LLC's largest Q4 2022 buy was Bunge Global: 75,525 shares worth $7.54M.
- Capital Analysts LLC added most to iShares 0-5 Year TIPS Bond ETF in Q4 2022, an estimated $50.4M increase.
- Capital Analysts LLC's biggest Q4 2022 reduction was State Street SPDR Bloomberg 1-10 Year TIPS ETF, cutting an estimated $52.5M.
- Capital Analysts LLC fully exited First Trust Nasdaq Semiconductor ETF in Q4 2022, selling an estimated $122K.
- Capital Analysts LLC's ten largest holdings make up 34% of its $1.64B portfolio in Q4 2022.
- Capital Analysts LLC opened 96 new positions and closed 133 in Q4 2022.
- Capital Analysts LLC's portfolio value rose 13% quarter-over-quarter to $1.64B.
Based on Capital Analysts LLC's 13F filing for Q4 2022, filed 8 Feb 2023.